EVENTS

Virtual 2021 SOT Annual Meeting and ToxExpo

ZeClinics is participating as exhibitor at the largest Toxicology event

ZECLINICS NEWS

Can you play with zebrafish genome for drug discovery?

EVENTS

SLAS2021 Digital International Conference and Exhibition

Flavia, one of our genetics experts, will present a poster entitled ZeGenesis, an innovative CRISPR/Cas9-based

Larvae zebrafish at ZeClinics ZECLINICS NEWS

R&D: What ZeClinics does?

ZECLINICS NEWS

The zebrafish model: A powerful tool for answering complex questions

Papers

Predicting teratogenicity modes of action in higher vertebrates

Zebrafish teratogenicity predictivity shown here reinforces the possibility of applying powerful mechanistic approaches.

Papers

Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function

The data presented contribute to delineate GRIN PTVs genotype-phenotype association and GRIN variants stratification

Papers

CRISPR Meets Zebrafish: Accelerating the Discovery of New Therapeutic Targets

We propose that zebrafish, with the use of CRISPR/Cas9 tools, could streamline functional genomic processes to bring biologically relevant knowledge on diseases.

ZeClinics PD ZECLINICS NEWS

Statistical Significance in Preclinical Study of Cannabinoid formulations against Parkinson’s Disease in Zebrafish

ZECLINICS NEWS

The Use of Zebrafish Genetics in Eradicating Diseases

ZECLINICS NEWS

Magnolia bark compound discovered to potentially treat drug-resistant epilepsy

ZeClinics DZNE Agreement ZECLINICS NEWS

ZeClinics Partners with German Center for Neurodegenerative Diseases (DZNE)

ZECLINICS NEWS

ZeCardio Therapeutics, spin-out de ZeClinics, abre su ronda de crowdfunding

ZeClinics GRINpatias ZECLINICS NEWS

ZeClinics une esfuerzos con IDIBELL para el estudio de las GRINpatias

CIRSPR CAS 9 ZECLINICS NEWS

Study shows that CRISPR-Cas9 gene editing has a low risk of mistakes in Zebrafish

CNIC HEART REANIMA ZECLINICS NEWS

REANIMA: towards the new horizon of cardiac regeneration